COMMUNIQUÉS West-GlobeNewswire

Kynos Therapeutics announces positive top-line results from the first-in-human Phase I study of its KMO inhibitor, KNS366, demonstrating safety, tolerability and target engagement
22/04/2024
EDINBURGH, United Kingdom, April 22, 2024 (GLOBE NEWSWIRE) -- Kynos Therapeutics Ltd, a clinical-stage biotechnology company developing first-in-class small molecule kynurenine 3-monooxygenase (KMO) inhibitors for acute [...]
Transactions in Connection with Share Buy-back Program Genmab
22/04/2024
Company Announcement COPENHAGEN, Denmark; April 22, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. [...]
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
22/04/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 22 APRIL 2024 at 9.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients
22/04/2024
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli [...]
Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results
22/04/2024
Press Release Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results Nicox Group revenue of €4.4 million (net revenue 1 €3.9 million) for first quarter 2024 Nicox Group cash of €9.1 million on [...]
Nicox : Point financier sur le premier trimestre 2024 et résultats financiers de l’année 2023
22/04/2024
Communiqué de presse Nicox : Point financier sur le premier trimestre 2024 et résultats financiers de l’année 2023 Chiffre d’affaires du Groupe de €4,4 millions (net 1 de €3,9 millions) pour le premier trimestre 2024 [...]
Samsung Bioepis Gains European Commission Approval For PYZCHIVA™, a Biosimilar to Stelara (Ustekinumab)
22/04/2024
PYZCHIVA becomes Samsung Bioepis’ fourth EC-approved immunology biosimilar Sandoz to commercialize PYZCHIVA in Europe INCHEON, Korea, April 22, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today announced that the [...]
Mithra secures court protection measures to advance monetization process
22/04/2024
Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing Organization. Approval of Judicial [...]
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
22/04/2024
Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaboration Following development candidate validation, Ipsen will assume responsibility for further [...]
Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares
22/04/2024
Ipsen conclut un accord d'option pour les droits mondiaux exclusifs des candidats retenus dans le cadre de cette collaboration Une fois le candidat au développement validé, Ipsen sera responsable de la poursuite de son [...]
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
22/04/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva ® approved as one of first ustekinumab biosimilars in Europe EC approval based on robust development program confirming match to [...]
Ibogaine By David Dardashti' Investigates Correlation between Alcohol Addiction and Chemical Depression
22/04/2024
Ibogaine Clinic Aims to Create Sustainable Solutions to Treat Alcohol Addiction Miami, April 21, 2024 (GLOBE NEWSWIRE) -- The Ibogaine clinic by David Dardashti has announced its latest investigation into the [...]
Ibogaine By David Dardashti Offers New Treatment Procedure In Dedication Of Autism Awareness Month
22/04/2024
Ibogaine By David Dardashti Is Paving the Way For Autistic People With The Latest Treatment Procedure MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- To commemorate Autism Awareness Month, Ibogaine By David Dardashti is [...]
Ibogaine By David Dardashti Initiates Collaboration with Top Psychedelic Researchers
21/04/2024
Ibogaine By David Dardashti Seeks to Enhance Treatment Algorithms and Knowledge of Ibogaine MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leading ibogaine provider in the world, is proud to [...]
Quantum Electrodynamics and Ibogaine: Enhancing Work Performance
21/04/2024
Ibogaine By David Dardashti claims improved treatment efficacy due to electromagnetic waves MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a leader in the field of ibogaine therapy, is [...]
Ibogaine By David Dardashti Encourages Patients to Practice Compassion
21/04/2024
Misty Huckabey explains how to Focus on Promoting Self-Love and Compassion MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, an organization that provides ibogaine-assisted addiction treatment, is [...]
Ibogaine By David Dardashti Offers Expanded Treatment Options
21/04/2024
Ibogaine By David Dardashti Enhances Treatment with Holistic Therapy Services MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce an expanded treatment program providing greater [...]
Ibogaine By David Dardashti Takes Pride in Participating in Sexual Awareness Month
21/04/2024
Clinic Works to Create New Solutions to Combat Sexual Assault MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is a specialized clinic that focuses on treating addiction, particularly in instances [...]
Ibogaine By David Dardashti Announces New Algorithm For Alcohol Addiction
21/04/2024
Revolutionary Method to Combat Alcoholism and Restore Quality of Life MIAMI, April 21, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti, a prominent provider of natural and holistic remedies for substance abuse, has [...]

Pages